Related Experiment Videos
Norplant in Zimbabwe: preliminary report
J Kasule1, T Chipato, A Zinanga
1Department of Obstetrics and Gynaecology, University of Zimbabwe Medical School, Avondale, Harare.
The Central African Journal of Medicine
|August 1, 1992
Summary
Norplant, a levonorgestrel contraceptive implant, demonstrated high acceptability and efficacy in a Zimbabwe trial. Continuation rates were significantly higher than other reversible methods, indicating its suitability for long-term birth control.
Area of Science:
- Reproductive Health
- Contraception
- Clinical Trials
Background:
- Norplant is a subdermal contraceptive implant containing levonorgestrel.
- Assessing the acceptability and efficacy of new contraceptive methods is crucial for reproductive health programs.
Purpose of the Study:
- To evaluate the acceptability and efficacy of Norplant during a pre-introduction trial in Zimbabwe.
- To assess Norplant's continuation rates compared to other reversible contraceptive methods.
Main Methods:
- A prospective study involving 197 women who received Norplant implants between June and December 1991.
- Data collection on acceptability, efficacy, side effects, and continuation rates.
Main Results:
- High acceptability and efficacy of Norplant were observed.
- No significant side effects were reported, with only three implants removed due to local infection.
- Norplant exhibited a much higher continuation rate than other reversible contraception methods.
Conclusions:
- Norplant is a highly acceptable and effective long-term contraceptive method.
- The high continuation rate suggests Norplant's potential as a preferred choice for reversible contraception.
Keywords:
AfricaAfrica South Of The SaharaContraceptionContraception ContinuationContraceptive AgentsContraceptive Agents, FemaleContraceptive Agents, ProgestinContraceptive EffectivenessContraceptive UsageDeveloping CountriesEastern AfricaEnglish Speaking AfricaFamily PlanningLevonorgestrelMethod AcceptabilityResearch ReportZimbabwe